课题基金 / 基金详情

Engineering Particle Nanostructure for Enhanced Bioadhesion

Engineering Particle Nanostructure for Enhanced Bioadhesion
用于增强生物粘附的工程颗粒纳米结构
批准号:
8074412
负责人:
Tejal A. Desai
金额:
$21.66万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2013-05-31

项目摘要

项目成果

Tejal A. Desai的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Oral delivery remains the preferred route for drug administration. However, therapeutic macromolecular drugs currently under development suffer from poor oral bioavailability. Nanotechnology may offer potential advantages over conventional drug delivery stratagems. In this proposal, we investigate nanofabrication approaches to create nanowire interfaces which promote bioadhesion under dynamic conditions. We examine nanostructure interactions with the underlying epithelium and the use of such interfaces to enhance the local delivery of drugs. The long-term objective of this proposal is to develop a new platform for oral delivery of pharmacologically active macromolecules into the systemic circulation via the creation of a robust bioadhesive delivery system. We propose the following specific aims: Specific Aim 1: Refine processes for optimal fabrication of highly uniform nanowire platforms of controllable size, feature geometry, mechanical integrity and uniformity Specific Aim 2: Examine mechanism of cell-nanowire bioadhesion and effects on drug release in vitro Specific Aim 3: Determine the in vivo bioadhesion of nanostructure particles using fluorescent imaging and microCT We expect to find that our nanowire-particles display enhanced bioadhesion compared to chemically modified particles. This may allow for an increase in particle residence time at the epithelial interface. In addition, the use of nanoarchitecture to enhance particle stability may mitigate issues associated with the stability of chemical modification in the GI system. PUBLIC HEALTH RELEVANCE: Oral delivery remains the preferred route for drug administration, particularly in the U.S. However, there are several issues related to adequate drug bioavailability and localization with the GI tract. We propose the use of nanostructure interfaces to enhance the bioadhesion of delivery devices to the GI tract.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.addr.2012.08.013
发表时间: 2012-11
期刊: ADVANCED DRUG DELIVERY REVIEWS
影响因子: 16.1
作者: [Chirra, Hariharasudhan D., Desai, Tejal A.]
通讯作者: Desai, Tejal A.
DOI: 10.1016/j.biomaterials.2011.01.022
发表时间: 2011-05
期刊: BIOMATERIALS
影响因子: 14
作者: [Fischer, Kathleen E., Nagaraj, Ganesh, Daniels, R. Hugh, Li, Esther, Cowles, Verne E., Miller, Jennifer L., Bunger, Mark D., Desai, Tejal A.]
通讯作者: Desai, Tejal A.
DOI: 10.1021/nl103951e
发表时间: 2011-03-09
期刊: Nano letters
影响因子: 10.8
作者: [Fischer KE, Jayagopal A, Nagaraj G, Daniels RH, Li EM, Silvestrini MT, Desai TA]
通讯作者: Desai TA
DOI: 10.1021/nn3019865
发表时间: 2012-09-25
期刊: ACS NANO
影响因子: 17.1
作者: [Uskokovic, Vuk, Lee, Kunwoo, Lee, Phin Peng, Fischer, Kathleen E., Desai, Tejal A.]
通讯作者: Desai, Tejal A.
Regulation of epithelial function using targeted nanowires
  • 批准号:
    10453894
  • 项目类别:
  • 资助金额:
    $63.13万
  • 财政年份:
    2022
  • 负责人:
    Tejal A. Desai
  • 依托单位:
Regulation of epithelial function using targeted nanowires
  • 批准号:
    10677028
  • 项目类别:
  • 资助金额:
    $61.25万
  • 财政年份:
    2022
  • 负责人:
    Tejal A. Desai
  • 依托单位:
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
海外基金